Over the past decades, the three antibody generation strategies, chemical conjugation, hybrid hybridomas and genetic engineering have resulted in over 67-70 different formats of bispecific antibodies. These BsAbs have been widely researched in diagnostic and therapeutic fields. We can provide BsAb engineering service to adjust the properties of BsAbs such as valency, size, half-life, flexibility, etc., to meet the specific requirements.